Neuland Laboratories Limited

NSE:NEULANDLAB.NS

12710.7 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 15,585.80511,911.989,253.039,242.6527,577.4826,459.8025,127.695,727.4215,099.7014,647.0354,656.9334,605.864,485.033,936.92,784.213,067.22
Cost of Revenue 10,505.5936,137.8535,535.025,586.9834,777.9474,431.5633,198.6113,259.3333,159.5822,996.2112,949.9263,174.543,231.883,129.912,177.452,460.15
Gross Profit 5,080.2125,774.1273,718.013,655.6692,799.5352,028.2391,929.0792,468.0881,940.1191,650.8241,707.0071,431.321,253.15806.99606.76607.07
Gross Profit Ratio 0.3260.4850.4020.3960.3690.3140.3760.4310.380.3550.3670.3110.2790.2050.2180.198
Reseach & Development Expenses 435277.576277.23210.658174.114166.321140.507119.522109.51782.422108.26290.2570000
General & Administrative Expenses 309.172262.924156.926134.892147.982126.719178.752104.62595.038563.08434.2624.2920362.37367.03348.95
Selling & Marketing Expenses 339.358295.793274.019204.833119.913118.09381.5157.328115.72881.453265.705135.1180000
SG&A 1,051.316558.717430.945339.725267.895244.812260.262104.62595.038644.537814.562702.3460362.37367.03348.95
Other Expenses 125.44397.48210.81813.35113.3329.9637.4571,654.311,195.21723.47923.167.72922.67120.72101.4436.04
Operating Expenses 1,051.3163,583.4742,763.0992,559.8952,076.6981,649.9821,639.0151,758.9351,290.2551,161.3091,156.519989.43922.67483.09468.47384.99
Operating Income 4,028.8962,305.566960.9031,096.333735.987384.476290.064709.153649.864489.515550.488441.89330.48323.9138.29222.08
Operating Income Ratio 0.2580.1940.1040.1190.0970.060.0570.1240.1270.1050.1180.0960.0740.0820.050.072
Total Other Income Expenses Net -14.531-148.102-139.278-42.998-206.762-181.103-150.72-214.969-229.835-242.297-204.953-252.65-322.17-274.52-236.43-75.95
Income Before Tax 4,014.3652,157.464821.6251,053.335529.225203.373139.344494.184420.029247.218345.535189.248.3149.38-98.14146.13
Income Before Tax Ratio 0.2580.1810.0890.1140.070.0310.0270.0860.0820.0530.0740.0410.0020.013-0.0350.048
Income Tax Expense 1,013.576522.288183.405247.028367.1238.95718.715166.154149.23587.89777.99728.08-17.39-3.3-28.9326.93
Net Income 3,000.7891,635.176638.22806.307162.105164.416120.629328.03273.245159.469268.073138.6325.6152.89-69.05119.23
Net Income Ratio 0.1930.1370.0690.0870.0210.0250.0240.0570.0540.0340.0580.030.0060.013-0.0250.039
EPS 233.89127.4549.7462.8512.6413.0610.8142.0130.7618.6733.8417.334.058.06-10.5718.24
EPS Diluted 233.89127.4549.7462.8512.6413.0610.8142.0130.7518.6633.8317.314.048.05-10.5718.21
EBITDA 4,625.8952,815.9091,425.4431,571.098999.652562.423492.627827.299734.272583.687699.874577.89479.39478.01261.92295.78
EBITDA Ratio 0.2970.2360.1540.170.1320.0870.0960.1440.1440.1260.150.1250.1070.1210.0940.096